News
17h
Zacks.com on MSNHims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while ...
Through a trust, Dudum sold about $33.4 million worth of his company's stock on Thursday, according to a filing with the Securities and Exchange Commission put out after Monday's closing bell. The CEO ...
While Wall Street analysts remain cautious on Hims & Hers Health (HIMS), TipRanks’ A.I. Stock Analysis tool shows strong ...
Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.
Current health news highlights include UK investor backing in Assura's acquisition by PHP, Novo Nordisk's legal affairs over Wegovy drug sales, and Apollo Hospitals' increased AI investments. The CDC ...
Doon University-BCYW Foundation's Event Speakers Addressing the Audience. Audience Keenly Waiting to Learn from the Speakers. Speake ...
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.
Weed is no longer just for hippies or hip-hop stars — around 22 million people in the U.S. are cannabis users. But there’s ...
Shedeur Sanders shares unusual deep conversation with referee during NFL preseason debut with Browns
Shedeur Sanders' NFL debut had plenty of anticipation, but it wasn't just his throws that caught fans' attention. The Cleveland Browns rookie quarterback found himself in a moment ...
Detailed price information for Gsi Technology Inc (GSIT-Q) from The Globe and Mail including charting and trades.
May 31, 2021. China's vast manufacturing sector grew at the fastest pace in eight months in May, blowing past e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results